Editing Cancer (TRPM7)

{{tp|p=30338939|t=2018. Prostaglandin E2 increases migration and proliferation of human glioblastoma cells by activating transient receptor potential melastatin 7 channels.|pdf=|usr=}}{{30338939}}
{{tp|p=22355351|t=2012. Kinome-wide functional genomics screen reveals a novel mechanism of TNFalpha-induced nuclear accumulation of the HIF-1alpha transcription factor in cancer cells.|pdf=|usr=}}{{22355351}}
{{tp|p=38156103|t=2023. OIP5-AS1/CD147/TRPM7 axis promotes gastric cancer metastasis by regulating apoptosis related PI3K-Akt signaling.|pdf=|usr=}}{{38156103}}
{{tp|p=37839677|t=2023. Roles of TRPM7 in ovarian cancer.|pdf=|usr=}}{{37839677}}
{{tp|p=37642779|t=2023. TRPM7 transactivates the FOSL1 gene through STAT3 and enhances glioma stemness.|pdf=|usr=}}{{37642779}}
{{tp|p=37507867|t=2023. TRP Channels in Tumoral Processes Mediated by Oxidative Stress and Inflammation.|pdf=|usr=}}{{37507867}}
{{tp|p=36878949|t=2023. The TRPM7 channel reprograms cellular glycolysis to drive tumorigenesis and angiogenesis.|pdf=|usr=}}{{36878949}}
{{tp|p=36818331|t=2023. Cardiovascular toxicity of tyrosine kinase inhibitors during cancer treatment: Potential involvement of TRPM7.|pdf=|usr=}}{{36818331}}
{{tp|p=36363540|t=2022. Clinical and Prognostic Values of TRPM7 in Colon and Rectal Cancers.|pdf=|usr=}}{{36363540}}
{{tp|p=36064388|t=2022. Promoter methylation of transient receptor potential melastatin-related 7 (TRPM7) predicts a better prognosis in patients with Luminal A breast cancers.|pdf=|usr=}}{{36064388}}
{{tp|p=35771152|t=2022. TRPM7 via calcineurin/NFAT pathway mediates metastasis and chemotherapeutic resistance in head and neck squamous cell carcinoma.|pdf=|usr=}}{{35771152}}
{{tp|p=35711942|t=2022. Differential Expression of Genes Regulating Store-operated Calcium Entry in Conjunction With Mitochondrial Dynamics as Potential Biomarkers for Cancer: A Single-Cell RNA Analysis.|pdf=|usr=}}{{35711942}}
{{tp|p=35242236|t=2022. Transient receptor potential channels in multiple myeloma.|pdf=|usr=}}{{35242236}}
{{tp|p=35101076|t=2022. TRPM7 silencing modulates glucose metabolic reprogramming to inhibit the growth of ovarian cancer by enhancing AMPK activation to promote HIF-1alpha degradation.|pdf=|usr=}}{{35101076}}
{{tp|p=34944940|t=2021. TRPM7 Ion Channel: Oncogenic Roles and Therapeutic Potential in Breast Cancer.|pdf=|usr=}}{{34944940}}
{{tp|p=34938330|t=2021. Prognostic Value of TRPM7 Expression and Factor XIIIa-Expressing Tumor-Associated Macrophages in Gastric Cancer.|pdf=|usr=}}{{34938330}}
{{tp|p=34901284|t=2021. hsa_circ_0023305 Enhances Laryngeal Squamous Cell Carcinoma Progression and Modulates TRPM7 via miR-218-5p Sponging.|pdf=|usr=}}{{34901284}}
{{tp|p=34285910|t=2021. Oridonin Promotes Apoptosis and Restrains the Viability and Migration of Bladder Cancer by Impeding TRPM7 Expression via the ERK and AKT Signaling Pathways.|pdf=|usr=}}{{34285910}}
{{tp|p=34244134|t=2021. The fluid shear stress sensor TRPM7 regulates tumor cell intravasation.|pdf=|usr=}}{{34244134}}
{{tp|p=34042256|t=2021. Tumor suppressor miR-192-5p targets TRPM7 and inhibits proliferation and invasion in cervical cancer.|pdf=|usr=}}{{34042256}}
{{tp|p=33891828|t=2021. Leptin Induces Epigenetic Regulation of Transient Receptor Potential Melastatin 7 in Rat Adrenal Pheochromocytoma Cells.|pdf=|usr=}}{{33891828}}
{{tp|p=33617107|t=2021. Expression and prognostic value of TRPM7 in canine mammary tumours.|pdf=|usr=}}{{33617107}}
{{tp|p=33435261|t=2021. Lidocaine Suppresses Viability and Migration of Human Breast Cancer Cells: TRPM7 as a Target for Some Breast Cancer Cell Lines.|pdf=|usr=}}{{33435261}}
{{tp|p=33381038|t=2020. TRPM7 Induces Tumorigenesis and Stemness Through Notch Activation in Glioma.|pdf=|usr=}}{{33381038}}
{{tp|p=33310045|t=2021. Carvacrol affects breast cancer cells through TRPM7 mediated cell cycle regulation.|pdf=|usr=}}{{33310045}}
{{tp|p=37495546|t=2023. Sinomenine regulates circTRPM7-related pathway to inhibit gastric cancer cell growth and metastasis.|pdf=|usr=}}{{37495546}}
{{tp|p=36332746|t=2022. A pan-cancer-bioinformatic-based literature review of TRPM7 in cancers.|pdf=|usr=}}{{36332746}}
{{tp|p=34958137|t=2022. Suppression of transient receptor potential melastatin 7 regulates pluripotency, proliferation, and differentiation of mouse embryonic stem cells via mechanistic target of rapamycin-extracellular signal-regulated kinase activation.|pdf=|usr=}}{{34958137}}
{{tp|p=34953296|t=2022. Modulators of TRPM7 and its potential as a drug target for brain tumours.|pdf=|usr=}}{{34953296}}
{{tp|p=34752845|t=2022. Stimulating TRPM7 suppresses cancer cell proliferation and metastasis by inhibiting autophagy.|pdf=|usr=}}{{34752845}}
{{tp|p=33784560|t=2021. Role of TRPM7 kinase in cancer.|pdf=|usr=}}{{33784560}}
{{tp|p=33080445|t=2020. Inhibition of TRPM7 with waixenicin A reduces glioblastoma cellular functions.|pdf=|usr=}}{{33080445}}
{{tp|p=32505565|t=2020. TRPM7 is overexpressed in human IBD-related and sporadic colorectal cancer and correlates with tumor grade.|pdf=|usr=}}{{32505565}}
{{tp|p=32468675|t=2020. Suppression of TRPM7 enhances TRAIL-induced apoptosis in triple-negative breast cancer cells.|pdf=|usr=}}{{32468675}}
{{tp|p=31844251|t=2020. Inhibition of TRPM7 blocks MRTF/SRF-dependent transcriptional and tumorigenic activity.|pdf=|usr=}}{{31844251}}
{{tp|p=31640089|t=2019. TRPM7 deficiency suppresses cell proliferation, migration, and invasion in human colorectal cancer via regulation of epithelial-mesenchymal transition.|pdf=|usr=}}{{31640089}}
{{tp|p=30710498|t=2019. miR-543 inhibites cervical cancer growth and metastasis by targeting TRPM7.|pdf=|usr=}}{{30710498}}
{{tp|p=30513244|t=2019. Effects of Salivary Mg on Head and Neck Carcinoma via TRPM7.|pdf=|usr=}}{{30513244}}
{{tp|p=29545479|t=2018. TRPM7 Regulates AKT/FOXO1-Dependent Tumor Growth and Is an Independent Prognostic Indicator in Renal Cell Carcinoma.|pdf=|usr=}}{{29545479}}
{{tp|p=32907556|t=2020. Knockdown of TRPM7 prevents tumor growth, migration, and invasion through the Src, Akt, and JNK pathway in bladder cancer.|pdf=|usr=}}{{32907556}}
{{tp|p=32801754|t=2020. Long Noncoding RNA ST7-AS1 Upregulates TRPM7 Expression by Sponging microRNA-543 to Promote Cervical Cancer Progression.|pdf=|usr=}}{{32801754}}
{{tp|p=32733880|t=2020. TRPM7/RPSA Complex Regulates Pancreatic Cancer Cell Migration.|pdf=|usr=}}{{32733880}}
{{tp|p=32684624|t=2020. A novel TRPM7/O-GlcNAc axis mediates tumour cell motility and metastasis by stabilising c-Myc and caveolin-1 in lung carcinoma.|pdf=|usr=}}{{32684624}}
{{tp|p=32390858|t=2020. Isoproterenol-Dependent Activation of TRPM7 Protects Against Neurotoxin-Induced Loss of Neuroblastoma Cells.|pdf=|usr=}}{{32390858}}
{{tp|p=32215176|t=2020. Suppression of TRPM7 Inhibited Hypoxia-Induced Migration and Invasion of Androgen-Independent Prostate Cancer Cells by Enhancing RACK1-Mediated Degradation of HIF-1alpha.|pdf=|usr=}}{{32215176}}
{{tp|p=31947967|t=2020. The Role of Transient Receptor Potential Melastatin 7 (TRPM7) in Cell Viability: A Potential Target to Suppress Breast Cancer Cell Cycle.|pdf=|usr=}}{{31947967}}
{{tp|p=31921670|t=2019. TRPM7 Induces Mechanistic Target of Rap1b Through the Downregulation of miR-28-5p in Glioma Proliferation and Invasion.|pdf=|usr=}}{{31921670}}
{{tp|p=31636470|t=2019. Role of ion channels in gastrointestinal cancer.|pdf=|usr=}}{{31636470}}
{{tp|p=31293101|t=2019. TRPM7 is involved in acid-induced necrotic cell death in a manner sensitive to progesterone in human cervical cancer cells.|pdf=|usr=}}{{31293101}}
{{tp|p=30279961|t=2018. The vesicular transfer of CLIC1 from glioblastoma to microvascular endothelial cells requires TRPM7.|pdf=|usr=}}{{30279961}}
{{tp|p=29984342|t=2018. Down-regulation of transient receptor potential melastatin member 7 prevents migration and invasion of renal cell carcinoma cells via inactivation of the Src and Akt pathway.|pdf=|usr=}}{{29984342}}
{{tp|p=29875336|t=2018. TRPM Family Channels in Cancer.|pdf=|usr=}}{{29875336}}
{{tp|p=29684587|t=2018. TRPM7 controls mesenchymal features of breast cancer cells by tensional regulation of SOX4.|pdf=|usr=}}{{29684587}}
{{tp|p=28810912|t=2017. Inhibition of TRPM7 suppresses cell proliferation of colon adenocarcinoma in vitro and induces hypomagnesemia in vivo without affecting azoxymethane-induced early colon cancer in mice.|pdf=|usr=}}{{28810912}}
{{tp|p=28791418|t=2017. TRPM7 is overexpressed in bladder cancer and promotes proliferation, migration, invasion and tumor growth.|pdf=|usr=}}{{28791418}}
{{tp|p=28533887|t=2017. Lidocaine suppresses glioma cell proliferation by inhibiting TRPM7 channels.|pdf=|usr=}}{{28533887}}
{{tp|p=28462107|t=2016. Role of transient receptor potential melastatin type 7 channel in gastric cancer.|pdf=|usr=}}{{28462107}}
{{tp|p=28314277|t=2017. Transient Receptor Potential Melastatin 7 as an Independent Prognostic Factor in Human Esophageal Squamous Cell Carcinoma.|pdf=|usr=}}{{28314277}}
{{tp|p=28161478|t=2017. Identification of TG100-115 as a new and potent TRPM7 kinase inhibitor, which suppresses breast cancer cell migration and invasion.|pdf=|usr=}}{{28161478}}
{{tp|p=27693494|t=2016. Bradykinin promotes migration and invasion of hepatocellular carcinoma cells through TRPM7 and MMP2.|pdf=|usr=}}{{27693494}}
{{tp|p=27629139|t=2016. TRPM7 channel inhibition mediates midazolam-induced proliferation loss in human malignant glioma.|pdf=|usr=}}{{27629139}}
{{tp|p=27604090|t=2016. Recent Advances in Oncogenic Roles of the TRPM7 Chanzyme.|pdf=|usr=}}{{27604090}}
{{tp|p=27402209|t=2016. The TRPM7 interactome defines a cytoskeletal complex linked to neuroblastoma progression.|pdf=|usr=}}{{27402209}}
{{tp|p=26918850|t=2016. Magnesium Modulates Doxorubicin Activity through Drug Lysosomal Sequestration and Trafficking.|pdf=|usr=}}{{26918850}}
{{tp|p=26779625|t=2016. Functional characterization of TRPM7 in nasopharyngeal carcinoma and its knockdown effects on tumorigenesis.|pdf=|usr=}}{{26779625}}
{{tp|p=26088448|t=2015. Gene expressions of TRP channels in glioblastoma multiforme and relation with survival.|pdf=|usr=}}{{26088448}}
{{tp|p=25450691|t=2014. TRPM7 is required for ovarian cancer cell growth, migration and invasion.|pdf=|usr=}}{{25450691}}
{{tp|p=25304381|t=2015. TRPM7 promotes the metastatic process in human nasopharyngeal carcinoma.|pdf=|usr=}}{{25304381}}
{{tp|p=25069584|t=2014. Oncogenic role and therapeutic target of transient receptor potential melastatin 7 channel in malignancy.|pdf=|usr=}}{{25069584}}
{{tp|p=28410232|t=2017. Vacquinol-1 inducible cell death in glioblastoma multiforme is counter regulated by TRPM7 activity induced by exogenous ATP.|pdf=|usr=}}{{28410232}}
{{tp|p=28379203|t=2017. Role of TRPM7 in Cancer: Potential as Molecular Biomarker and Therapeutic Target.|pdf=|usr=}}{{28379203}}
{{tp|p=28284058|t=2017. The Transient Receptor Potential Melastatin 7 Channel Regulates Pancreatic Cancer Cell Invasion through the Hsp90alpha/uPA/MMP2 pathway.|pdf=|usr=}}{{28284058}}
{{tp|p=28101241|t=2016. Potential role of melastatin-related transient receptor potential cation channel subfamily M gene expression in the pathogenesis of urinary bladder cancer.|pdf=|usr=}}{{28101241}}
{{tp|p=28094304|t=2017. The different expression of TRPM7 and MagT1 impacts on the proliferation of colon carcinoma cells sensitive or resistant to doxorubicin.|pdf=|usr=}}{{28094304}}
{{tp|p=28061441|t=2017. Activation of TRPM7 by naltriben enhances migration and invasion of glioblastoma cells.|pdf=|usr=}}{{28061441}}
{{tp|p=27803760|t=2016. Carvacrol Alleviates Prostate Cancer Cell Proliferation, Migration, and Invasion through Regulation of PI3K/Akt and MAPK Signaling Pathways.|pdf=|usr=}}{{27803760}}
{{tp|p=27662662|t=2016. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.|pdf=|usr=}}{{27662662}}
{{tp|p=27185858|t=2016. TRPM7 is a molecular substrate of ATP-evoked P2X7-like currents in tumor cells.|pdf=|usr=}}{{27185858}}
{{tp|p=26703785|t=2016. Quantitative imaging of magnesium distribution at single-cell resolution in brain tumors and infiltrating tumor cells with secondary ion mass spectrometry (SIMS).|pdf=|usr=}}{{26703785}}
{{tp|p=26563869|t=2015. Magnesium homeostasis in colon carcinoma LoVo cells sensitive or resistant to doxorubicin.|pdf=|usr=}}{{26563869}}
{{tp|p=15286426|t=2004. Involvement of TRPM7 in cell growth as a spontaneously activated Ca2+ entry pathway in human retinoblastoma cells.|pdf=|usr=}}{{15286426}}
{{tp|p=23910495|t=2013. Transient receptor potential melastatin 7 is involved in oestrogen receptor-negative metastatic breast cancer cells migration through its kinase domain.|pdf=|usr=}}{{23910495}}
{{tp|p=23353055|t=2013. TRPM7 mediates breast cancer cell migration and invasion through the MAPK pathway.|pdf=|usr=}}{{23353055}}
{{tp|p=22671428|t=2012. Magnesium and its transporters in cancer: a novel paradigm in tumour development.|pdf=|usr=}}{{22671428}}
{{tp|p=22308955|t=2012. The role of transient receptor potential channel blockers in human gastric cancer cell viability.|pdf=|usr=}}{{22308955}}
{{tp|p=21978419|t=2011. EGF enhances the migration of cancer cells by up-regulation of TRPM7.|pdf=|usr=}}{{21978419}}
{{tp|p=20363498|t=2010. TRPM7 regulates the migration of human nasopharyngeal carcinoma cell by mediating Ca(2+) influx.|pdf=|usr=}}{{20363498}}
{{tp|p=18826101|t=2008. [Transient receptor potential melastatin 7 channel protein in human head and neck carcinoma cells and role in cell proliferation].|pdf=|usr=}}{{18826101}}
{{tp|p=25965832|t=2015. Inhibition of TRPM7 by carvacrol suppresses glioblastoma cell proliferation, migration and invasion.|pdf=|usr=}}{{25965832}}
{{tp|p=25913706|t=2015. Xyloketal B suppresses glioblastoma cell proliferation and migration in vitro through inhibiting TRPM7-regulated PI3K/Akt and MEK/ERK signaling pathways.|pdf=|usr=}}{{25913706}}
{{tp|p=25797249|t=2015. TRPM7 maintains progenitor-like features of neuroblastoma cells: implications for metastasis formation.|pdf=|usr=}}{{25797249}}
{{tp|p=25770184|t=2015. Aberrant over-expression of TRPM7 ion channels in pancreatic cancer: required for cancer cell invasion and implicated in tumor growth and metastasis.|pdf=|usr=}}{{25770184}}
{{tp|p=25438992|t=2015. Suppression of TRPM7 inhibits proliferation, migration, and invasion of malignant human glioma cells.|pdf=|usr=}}{{25438992}}
{{tp|p=25426416|t=2014. MycN promotes TRPM7 expression and cell migration in neuroblastoma through a process that involves polyamines.|pdf=|usr=}}{{25426416}}
{{tp|p=25367030|t=2014. TRPM7 involvement in cancer: a potential prognostic factor.|pdf=|usr=}}{{25367030}}
{{tp|p=25277194|t=2014. N-Myc-induced up-regulation of TRPM6/TRPM7 channels promotes neuroblastoma cell proliferation.|pdf=|usr=}}{{25277194}}
{{tp|p=25192910|t=2014. TRPM7 channels regulate glioma stem cell through STAT3 and Notch signaling pathways.|pdf=|usr=}}{{25192910}}
{{tp|p=24952306|t=2014. The association between single-nucleotide polymorphisms of TRPM7 gene and breast cancer in Han Population of Northeast China.|pdf=|usr=}}{{24952306}}
{{tp|p=24935580|t=2014. Overexpression of TRPM7 is associated with poor prognosis in human ovarian carcinoma.|pdf=|usr=}}{{24935580}}
{{tp|p=24849279|t=2014. Potential role of transient receptor potential (TRP) channels in bladder cancer cells.|pdf=|usr=}}{{24849279}}
{{tp|p=24556627|t=2013. From magnesium to magnesium transporters in cancer: TRPM7, a novel signature in tumour development.|pdf=|usr=}}{{24556627}}
{{tp|p=24176224|t=2013. TRPM7 triggers Ca2+ sparks and invadosome formation in neuroblastoma cells.|pdf=|usr=}}{{24176224}}
{{tp|p=23686305|t=2014. Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent.|pdf=|usr=}}{{23686305}}
{{tp|p=23662076|t=2012. Serum calcium levels, TRPM7, TRPC1, microcalcifications, and breast cancer using breast imaging reporting and data system scores.|pdf=|usr=}}{{23662076}}
{{tp|p=23594099|t=2013. Remodeling of calcium signaling in tumor progression.|pdf=|usr=}}{{23594099}}
{{tp|p=23168410|t=2013. Increase in serum Ca2+/Mg2+ ratio promotes proliferation of prostate cancer cells by activating TRPM7 channels.|pdf=|usr=}}{{23168410}}
{{tp|p=25780645|t=2012. Involvement of Transient Receptor Potential Melastatin 7 Channels in Sophorae Radix-induced Apoptosis in Cancer Cells: Sophorae Radix and TRPM7.|pdf=|usr=}}{{25780645}}
{{tp|p=22897572|t=2012. Role of TRPM in melanocytes and melanoma.|pdf=|usr=}}{{22897572}}
{{tp|p=22871386|t=2012. TRPM7 is required for breast tumor cell metastasis.|pdf=|usr=}}{{22871386}}
{{tp|p=22640890|t=2012. Canaux cationiques TRP dans le cancer du sein : expression, role et correlation avec des parametres cliniques.|pdf=|usr=}}{{22640890}}
{{tp|p=22323115|t=2012. Transient receptor potential melastatin-related 7 channel is overexpressed in human pancreatic ductal adenocarcinomas and regulates human pancreatic cancer cell migration.|pdf=|usr=}}{{22323115}}
{{tp|p=24278689|t=2012. TRPM7 and TRPM8 Ion Channels in Pancreatic Adenocarcinoma: Potential Roles as Cancer Biomarkers and Targets.|pdf=|usr=}}{{24278689}}
{{tp|p=22178934|t=2011. High expression of transient receptor potential channels in human breast cancer epithelial cells and tissues: correlation with pathological parameters.|pdf=|usr=}}{{22178934}}
{{tp|p=22166235|t=2012. Targeted silencing of TRPM7 ion channel induces replicative senescence and produces enhanced cytotoxicity with gemcitabine in pancreatic adenocarcinoma.|pdf=|usr=}}{{22166235}}
{{tp|p=21183474|t=2011. Transient receptor potential ion channel Trpm7 regulates exocrine pancreatic epithelial proliferation by Mg2+-sensitive Socs3a signaling in development and cancer.|pdf=|usr=}}{{21183474}}
{{tp|p=19515901|t=2009. Evidence that TRPM7 is required for breast cancer cell proliferation.|pdf=|usr=}}{{19515901}}
{{tp|p=19032368|t=2008. Suppression of transient receptor potential melastatin 7 channel induces cell death in gastric cancer.|pdf=|usr=}}{{19032368}}
{{tp|p=18006838|t=2007. Transient receptor potential melastatin 7-like current in human head and neck carcinoma cells: role in cell proliferation.|pdf=|usr=}}{{18006838}}
{{tp|p=17823441|t=2007. The relation of magnesium and calcium intakes and a genetic polymorphism in the magnesium transporter to colorectal neoplasia risk.|pdf=|usr=}}{{17823441}}
{{tp|p=17632567|t=2007. TRP-ing up melanophores: TRPM7, melanin synthesis, and pigment cell survival.|pdf=|usr=}}{{17632567}}
{{tp|p=34950031|t=2021. Mechanisms of Cancer Inhibition by Local Anesthetics.|pdf=|usr=}}{{34950031}}
{{tp|p=31801263|t=2019. Transient Receptor Potential Cation Channels in Cancer Therapy.|pdf=|usr=}}{{31801263}}
{{tp|p=17290233|t=2007. Cell death of melanophores in zebrafish trpm7 mutant embryos depends on melanin synthesis.|pdf=|usr=}}{{17290233}}
{{ttp|p=36006540|t=2023. The Supplement of Magnesium Element to Inhibit Colorectal Tumor Cells.|pdf=|usr=}}{{36006540}}
{{ttp|p=35600975|t=2023. Mg-based materials diminish tumor spreading and cancer metastases.|pdf=|usr=}}{{35600975}}
{{tp|p=35454136|t=2022. Transient Receptor Potential (TRP) Channels: Markers and Therapeutic Targets for Cancer?|pdf=|usr=}}{{35454136}}
{{tp|p=34065398|t=2021. Transient Receptor Potential (TRP) Channels in Haematological Malignancies: An Update.|pdf=|usr=}}{{34065398}}
{{tp|p=32887220|t=2020. pH-Channeling in Cancer: How pH-Dependence of Cation Channels Shapes Cancer Pathophysiology.|pdf=|usr=}}{{32887220}}
{{tp|p=32172727|t=2020. Emerging role of transient receptor potential (TRP) channels in cancer progression.|pdf=|usr=}}{{32172727}}
{{tp|p=30876463|t=2019. Lidocaine inhibits growth, migration and invasion of gastric carcinoma cells by up-regulation of miR-145.|pdf=|usr=}}{{30876463}}
{{tp|p=29186827|t=2017. Eukaryotic Elongation Factor 2 Kinase (eEF2K) in Cancer.|pdf=|usr=}}{{29186827}}
{{tp|p=28284204|t=2017. Calcium - Magnesium imbalance implicated in benign prostatic hyperplasia and restoration by a phytotherapeutic drug - Croton membranaceus Mull.Arg.|pdf=|usr=}}{{28284204}}
{{tp|p=24724725|t=2014. TRP channels and STIM/ORAI proteins: sensors and effectors of cancer and stroma cell migration.|pdf=|usr=}}{{24724725}}
{{tp|p=36844925|t=2022. On the modulation of TRPM channels: Current perspectives and anticancer therapeutic implications.|pdf=|usr=}}{{36844925}}
{{tp|p=36186485|t=2022. Development and validation of a TRP-related gene signature for overall survival prediction in lung adenocarcinoma.|pdf=|usr=}}{{36186485}}
{{tp|p=34408981|t=2021. Perioperative Intravenous Lidocaine and Metastatic Cancer Recurrence - A Narrative Review.|pdf=|usr=}}{{34408981}}
{{tp|p=34178620|t=2021. TRP Channels Interactome as a Novel Therapeutic Target in Breast Cancer.|pdf=|usr=}}{{34178620}}
{{tp|p=33928077|t=2021. TRP Channels in Brain Tumors.|pdf=|usr=}}{{33928077}}
{{tp|p=33923883|t=2021. Imbalance of Mg Homeostasis as a Potential Biomarker in Colon Cancer.|pdf=|usr=}}{{33923883}}
{{tp|p=33163084|t=2020. Carvacrol: An In Silico Approach of a Candidate Drug on HER2, PI3Kalpha, mTOR, hER-alpha, PR, and EGFR Receptors in the Breast Cancer.|pdf=|usr=}}{{33163084}}
{{tp|p=32766241|t=2020. Repositioning Lidocaine as an Anticancer Drug: The Role Beyond Anesthesia.|pdf=|usr=}}{{32766241}}
{{tp|p=32742323|t=2020. Evaluation of the TRPM protein family as potential biomarkers for various types of human cancer using public database analyses.|pdf=|usr=}}{{32742323}}
{{tp|p=28706559|t=2017. Insights into the Roles of Midazolam in Cancer Therapy.|pdf=|usr=}}{{28706559}}
{{tp|p=25852478|t=2015. Cancer as a channelopathy: ion channels and pumps in tumor development and progression.|pdf=|usr=}}{{25852478}}
{{tp|p=37501216|t=2023. A narrative review on the role of magnesium in immune regulation, inflammation, infectious diseases, and cancer.|pdf=|usr=}}{{37501216}} 
{{tp|p=36430727|t=2022. Transient Receptor Potential (TRP) Channels in Tumor Vascularization.|pdf=|usr=}}{{36430727}}
{{tp|p=36012311|t=2022. The Association between TRP Channels Expression and Clinicopathological Characteristics of Patients with Pancreatic Adenocarcinoma.|pdf=|usr=}}{{36012311}}
{{tp|p=34950031|t=2021. Mechanisms of Cancer Inhibition by Local Anesthetics.|pdf=|usr=}}{{34950031}}
{{tp|p=34305611|t=2021. Antitumor Effects of Carvacrol and Thymol: A Systematic Review.|pdf=|usr=}}{{34305611}}
{{tp|p=32182937|t=2020. TRP Channels in Digestive Tract Cancers.|pdf=|usr=}}{{32182937}}
{{tp|p=31110973|t=2019. Tissue and Serum Trace Elements Concentration among Colorectal Patients: A Systematic Review of Case-Control Studies.|pdf=|usr=}}{{31110973}}
{{tp|p=28448473|t=2017. Transcriptomic Analysis of Calcium Remodeling in Colorectal Cancer.|pdf=|usr=}}{{28448473}}
{{tp|p=27618016|t=2016. Ion Channels in Brain Metastasis.|pdf=|usr=}}{{27618016}}
{{tp|p=25347473|t=2014. Membrane protein CNNM4-dependent Mg2+ efflux suppresses tumor progression.|pdf=|usr=}}{{25347473}}
{{tp|p=36983900|t=2023. Attenuation of Endoplasmic Reticulum Stress Enhances Carvacrol-Induced Apoptosis in Osteosarcoma Cell Lines.|pdf=|usr=}}{{36983900}}
{{tp|p=36837670|t=2023. Mechanosensitive Ion Channels and Their Role in Cancer Cells.|pdf=|usr=}}{{36837670}}
{{tp|p=36658649|t=2023. Metal ions and nanometallic materials in antitumor immunity: Function, application, and perspective.|pdf=|usr=}}{{36658649}}
{{tp|p=35614079|t=2022. Pan-cancer analyses reveal the genetic and pharmacogenomic landscape of transient receptor potential channels.|pdf=|usr=}}{{35614079}}
{{tp|p=34704011|t=2021. Biofunctional magnesium-coated Ti6Al4V scaffolds promote autophagy-dependent apoptosis in osteosarcoma by activating the AMPK/mTOR/ULK1 signaling pathway.|pdf=|usr=}}{{34704011}}
{{tp|p=35368816|t=2021. Hypomagnesemia in the Cancer Patient.|pdf=|usr=}}{{35368816}}
{{tp|p=31801263|t=2019. Transient Receptor Potential Cation Channels in Cancer Therapy.|pdf=|usr=}}{{31801263}}
{{tp|p=29537902|t=2018. Urinary Magnesium and Other Elements in Relation to Mammographic Breast Density, a Measure of Breast Cancer Risk.|pdf=|usr=}}{{29537902}}
{{tp|p=34312420|t=2021. Low serum magnesium concentration is associated with the presence of viable hepatocellular carcinoma tissue in cirrhotic patients.|pdf=|usr=}}
{{tp|p=33923895|t=2021. Assessment and Imaging of Intracellular Magnesium in SaOS-2 Osteosarcoma Cells and Its Role in Proliferation.|pdf=|usr=}}{{33923895}}
{{tp|p=33450887|t=2021. Mg(2+) Transporters in Digestive Cancers.|pdf=|usr=}}{{33450887}}
{{tp|p=29772843|t=2018. The Role of TRP Channels in the Metastatic Cascade.|pdf=|usr=}}{{29772843}}
{{tp|p=34938893|t=2021. Oral magnesium supplements for cancer treatment-induced hypomagnesemia: Results from a pilot randomized trial.|pdf=|usr=}}{{34938893}}
{{tp|p=25343568|t=2015. EGFR-TKI, erlotinib, causes hypomagnesemia, oxidative stress, and cardiac dysfunction: attenuation by NK-1 receptor blockade.|pdf=|usr=}}{{25343568}}
{{tp|p=20595681|t=2010. Effects of the EGFR Inhibitor Erlotinib on Magnesium Handling.|pdf=|usr=}}{{20595681}}
{{tp|p=C3046074|t=2011. A role for Trpm7 in pancreatic cancer?|pdf=|usr=}}{{C3046074}}
{{tp|p=C7650375|t=2020. CSIG-13. TRPM7 INDUCES TUMORIGENESIS AND STEMNESS THROUGH NOTCH ACTIVATION IN GLIOMA.|pdf=|usr=}}{{C7650375}}
{{tp|p=C6847576|t=2019. CSIG-05. TRPM7 INDUCES MECHANISTIC TARGET OF Rap1b THROUGH DOWNREGULATION OF miR-28-5p IN GLIOMA PROLIFERATION AND INVASION.|pdf=|usr=}}{{C6847576}}